Man Group
CRBU icon

Man Group’s Caribou Biosciences CRBU Stock Holding History

Man Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Buy
240,066
+162,856
+211% +$322K ﹤0.01% 2091
2026
Q1 		$147K Buy
77,210
+40,498
+110% +$69.5K ﹤0.01% 2329
2025
Q4 		$58.4K Buy
+36,712
New +$77.1K ﹤0.01% 2218
2024
Q1 		– Sell
-22,108
Closed -$127K – 2138
2023
Q4 		$127K Buy
+22,108
New +$109K ﹤0.01% 1962

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Man Group's CRBU Position: Q2 2026 in Review

Man Group increased its Caribou Biosciences (CRBU) stake by 211% in Q2 2026, buying an estimated $322K and bringing the position to 240,066 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

Man Group first reported a position in CRBU in Q4 2023 and has held it in 4 quarters since. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Man Group held 240,066 shares of Caribou Biosciences worth $423K as of Q2 2026.
  • Man Group bought 162,856 Caribou Biosciences shares in Q2 2026, an estimated $322K.
  • Caribou Biosciences made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2091 holding.
  • Man Group first reported a position in Caribou Biosciences in Q4 2023 and has held it in 4 quarters since.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.